High-salt intake and the renal expression of amino acid transporters in spontaneously hypertensive rats

American Journal of Physiology - Renal Physiology

Volumn 292, Issue 5, 2007, Pages

  Pinho, Maria João ^a   Serrão, Maria Paula ^a   Soares da Silva, Patrício ^a  

^a Inst of Pharmacol and Therapeutics   (Portugal)

Author keywords

ASCT2; B0AT1; Hypertension; Kidney; LAT2

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; AMINO ACID TRANSPORTER; CHLORIDE; CREATININE; DOPAMINE; HOMOVANILLIC ACID; LEVODOPA; POTASSIUM; SODIUM ION;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHLORIDE BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CREATININE URINE LEVEL; DOPAMINE URINE LEVEL; DOPAMINERGIC SYSTEM; FOOD INTAKE; KIDNEY TUBULE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL; POTASSIUM URINE LEVEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RAT; RENOVASCULAR HYPERTENSION; SALT INTAKE; SALT LOADING; SODIUM BLOOD LEVEL; SODIUM TRANSPORT; SODIUM URINE LEVEL; SPONTANEOUSLY HYPERTENSIVE RAT; UREA NITROGEN BLOOD LEVEL;

EID: 34247854815     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00465.2006     Document Type: Article

References (68)

1. Arendshorst WJ, Beierwaltes WH. Renal tubular reabsorption in spontaneously hypertensive rats. Am J Physiol Renal Fluid Electrolyte Physiol 237: F38-F47, 1979.
2. 0 is a rabbit epithelial cell brush-border protein. Am J Physiol Cell Physiol 281: C963-C971, 2001.
3. Ball SG, Oats NS, Lee MR. Urinary dopamine in man and rat: effects of inorganic salts on dopamine excretion. Clin Sci Mol Med 55: 167-173, 1978.
4. Beierwaltes WH, Arendshorst WJ, Klemmer PJ. Electrolyte and water balance in young spontaneously hypertensive rats. Hypertension 4: 908-915, 1982.
5. Broer A, Cavanaugh JA, Rasko JE, Broer S. The molecular basis of neutral aminoacidurias. Pflügers Arch 451: 511-517, 2006.
6. 0, a neutral amino acid transporter related to Hartnup disorder. J Biol Chem 279: 24467-24476, 2004.
7. Carey RM. Theodore Cooper Lecture: renal dopamine system: paracrine regulator of sodium homeostasis and blood pressure. Hypertension 38: 297-302, 2001.
8. Chen CJ, Lokhandwala MF. An impairment of renal tubular DA-1 receptor function as the causative factor for diminished natriuresis to volume expansion in spontaneously hypertensive rats. Clin Exp Hypertens 14: 615-628, 1992.
9. Clemitson JR, Pratt JR, Frantz S, Sacks S, Samani NJ. Kidney specificity of rat chromosome 1 blood pressure quantitative trait locus region. Hypertension 40: 292-297, 2002.
10. + exchange in isolated single proximal tubules of spontaneously hypertensive rats. J Hypertens 10: 969-978, 1992.
11. Felder RA, Seikaly MG, Cody P, Eisner GM, Jose PA. Attenuated renal response to dopaminergic drugs in spontaneously hypertensive rats. Hypertension 15: 560-569, 1990.
12. Frohlich ED, Varagic J. Sodium directly impairs target organ function in hypertension. Curr Opin Cardiol 20: 424-429, 2005.
13. Garg LC, Narang N. Sodium-potassium-adenosine triphosphatase in nephron segments of spontaneously hypertensive rats. J Lab Clin Med 106: 43-46, 1985.
14. Goldstein DS, Stull R, Eisenhofer G, Gill JR Jr. Urinary excretion of dihydroxyphenylalanine and dopamine during alterations of dietary salt intake in humans. Clin Sci (Lond) 76: 517-522, 1989.
15. + exchanger activity in renal OK cells through the activation of protein kinases A and C signalling cascades. Eur J Pharmacol 488: 51-59, 2004.
16. 0,+, exchange L-DOPA with neutral and basic amino acids in two clonal renal cell lines. J Membr Biol 186: 63-80, 2002.
17. Green BJ, Lee CS, Rasko JE. Biodistribution of the RD114/mammalian type D retrovirus receptor, RDR. J Gene Med 6: 249-259, 2004.
18. Grossman E, Hoffman A, Tamrat M, Armando I, Keiser HR, Goldstein DS. Endogenous dopa and dopamine responses to dietary salt loading in salt-sensitive rats. J Hypertens 9: 259-263, 1991.
19. Hegde SS, Jadhav AL, Lokhandwala MF. Role of kidney dopamine in the natriuretic response to volume expansion in rats. Hypertension 13: 828-834, 1989.
20. Herlitz H, Lundin S, Henning M, Aurell M, Karlberg BE, Berglund G. Hormonal pattern during development of hypertension in spontaneously hypertensive rats (SHR). Clin Exp Hypertens 4: 915-935, 1982.
21. Hussain T, Lokhandwala MF. Renal dopamine receptor function in hypertension. Hypertension 32: 187-197, 1998.
22. + RNA. Biochim Biophys Acta 1466: 61-70, 2000.
23. Jose PA, Eisner GM, Felder RA. Dopamine receptor-coupling defect in hypertension. Curr Hypertens Rep 4: 237-244, 2002.
24. Jose PA, Eisner GM, Felder RA. Role of dopamine receptors in the kidney in the regulation of blood pressure. Curr Opin Nephrol Hypertens 11: 87-92, 2002.
25. Kanai Y, Endou H. Heterodimeric amino acid transporters: molecular biology and pathological and pharmacological relevance. Curr Drug Metab 2: 339-354, 2001.
26. 0AT1, cause Hartnup disorder. Nat Genet 36: 999-1002, 2004.
27. --dependent proline transporter. Biochem J 386: 417-422, 2005.
28. Kuchel O, Racz K, Debinski W, Falardeau P, Buu NT. Contrasting dopaminergic patterns in two forms of genetic hypertension. Clin Exp Hypertens 9: 987-1008, 1987.
29. 1 dopamine receptor regulation of NHE3 during development in spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 280: R1650-R1656, 2001.
30. Lo M, Liu KL, Clemitson JR, Sassard J, Samani NJ. Chromosome 1 blood pressure QTL region influences renal function curve and salt sensitivity in SHR. Physiol Genomics 8: 15-21, 2002.
31. Mate A, de la Hermosa MA, Barfull A, Sanchez-Aguayo I, Planas JM, Vazquez CM. Decreased monosaccharide transport in renal brush-border membrane vesicles of spontaneously hypertensive rats. Cell Mol Life Sci 57: 165-174, 2000.
32. Mullins LJ, Bailey MA, Mullins JJ. Hypertension, kidney, and transgenics: a fresh perspective. Physiol Rev 86: 709-746, 2006.
33. Nakamura E, Sato M, Yang H, Miyagawa F, Harasaki M, Tomita K, Matsuoka S, Noma A, Iwai K, Minato N. 4F2 (CD98) heavy chain is associated covalently with an amino acid transporter and controls intracellular trafficking and membrane topology of 4F2 heterodimer. J Biol Chem 274: 3009-3016, 1999.
34. Ohbu K, Felder RA. Nephron specificity of dopamine receptor-adenylyl cyclase defect in spontaneous hypertension. Am J Physiol Renal Fluid Electrolyte Physiol 264: F274-F279, 1993.
35. + exchanger activity in normotensive and spontaneously hypertensive rat proximal tubular epithelial cells. Br J Pharmacol 142: 1343-1353, 2004.
36. - exchanger in immortalized SHR proximal tubular epithelial cells. Am J Physiol Renal Physiol 286: F1120-F1126, 2004.
37. Pelayo JC, Fildes RD, Eisner GM, Jose PA. Effects of dopamine blockade on renal sodium excretion. Am J Physiol Renal Fluid Electrolyte Physiol 245: F247-F253, 1983.
38. Pestana M, Faria MS, Oliveira JG, Baldaia J, Santos A, Guerra LE, Soares-da-Silva P. Assessment of renal dopaminergic system activity during the recovery of renal function in human kidney transplant recipients. Nephrol Dial Transplant 12: 2667-2672, 1997.
39. Pestana M, Jardim H, Afonso C, Serrao P, Santos N, Guerra L, Soares-da-Silva P. Renal dopaminergic system in nephrotic syndrome and after remission. Nephrol Dial Transplant 13: 2559-2562, 1998.
40. Pineda M, Fernandez E, Torrents D, Estevez R, Lopez C, Camps M, Lloberas J, Zorzano A, Palacin M. Identification of a membrane protein, LAT-2, that coexpresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids. J Biol Chem 274: 19738-19744, 1999.
41. Pinho MJ, Gomes P, Serrao MP, Bonifacio MJ, Soares-da-Silva P. Organ-specific overexpression of renal LAT2 and enhanced tubular L-DOPA uptake precede the onset of hypertension. Hypertension 42: 613-618, 2003.
42. Pinho MJ, Serrao MP, Gomes P, Hopfer U, Jose PA, Soares-da-Silva P. Overexpression of renal LAT1 and LAT2 and enhanced L-DOPA uptake in SHR immortalized renal proximal tubular cells. Kidney Int 66: 216-226, 2004.
43. Pinto-do OP, Soares-da-Silva P. Studies on the pharmacology of the inward transport of L-DOPA in rat renal tubules. Br J Pharmacol 118: 741-747, 1996.
44. Quan H, Athirakul K, Wetsel WC, Torres GE, Stevens R, Chen YT, Coffman TM, Caron MG. Hypertension and impaired glycine handling in mice lacking the orphan transporter XT2. Mol Cell Biol 24: 4166-4173, 2004.
45. Racz K, Kuchel O, Buu NT, Tenneson S. Peripheral dopamine synthesis and metabolism in spontaneously hypertensive rats. Circ Res 57: 889-897, 1985.
46. Roman RJ, Cowley AW Jr. Abnormal pressure-diuresis-natriuresis response in spontaneously hypertensive rats. Am J Physiol Renal Fluid Electrolyte Physiol 248: F199-F205, 1985.
47. Rossier G, Meier C, Bauch C, Summa V, Sordat B, Verrey F, Kuhn LC. LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine. J Biol Chem 274: 34948-34954, 1999.
48. Sanada H, Watanabe H, Shigetomi S, Fukuchi S. Gene expression of aromatic L-amino acid decarboxylase mRNA in the kidney of normotensive and hypertensive rats. Hypertens Res 18, Suppl 1: S179-S181, 1995.
49. +-independent neutral amino acid transporter with broad substrate selectivity. J Biol Chem 274: 19745-19751, 1999.
50. Siragy HM, Felder RA, Howell NL, Chevalier RL, Peach MJ, Carey RM. Evidence that intrarenal dopamine acts as a paracrine substance at the renal tubule. Am J Physiol Renal Fluid Electrolyte Physiol 257: F469-F477, 1989.
51. Soares-da-Silva P. Enhanced protein kinase C mediated inhibition of renal dopamine synthesis during high sodium intake. Biochem Pharmacol 45: 1791-1800, 1993.
52. Soares-da-Silva P, Fernandes MH. Regulation of dopamine synthesis in the rat kidney. J Auton Pharmacol 10, Suppl 1: s25-s30, 1990.
53. Soares-da-Silva P, Fernandes MH. Sodium dependence and ouabain sensitivity of the synthesis of dopamine in renal tissues of the rat. Br J Pharmacol 105: 811-816, 1992.
54. Soares-da-Silva P, Fernandes MH, Pestana M. Studies on the role of sodium on the synthesis of dopamine in the rat kidney. J Pharmacol Exp Ther 264: 406-414, 1993.
55. Soares-da-Silva P, Fernandes MH, Pinto-do OP. Cell inward transport of L-DOPA and 3-O-methyl-L-DOPA in rat renal tubules. Br J Pharmacol 112: 611-615, 1994.
56. Soares-da-Silva P, Pestana M, Fernandes MH. Involvement of tubular sodium in the formation of dopamine in the human renal cortex. J Am Soc Nephrol 3: 1591-1599, 1993.
57. Soares-da-Silva P, Pestana M, Vieira-Coelho MA, Fernandes MH, Albino-Teixeira A. Assessment of renal dopaminergic system activity in the nitric oxide-deprived hypertensive rat model. Br J Pharmacol 114: 1403-1413, 1995.
58. 1 cells. Am J Physiol Renal Physiol 274: F243-F251, 1998.
59. +-dependent neutral amino acid transporter. J Biol Chem 271: 14883-14890, 1996.
60. Vieira-Coelho MA, Hussain T, Kansra V, Serrao MP, Guimaraes JT, Pestana M, Soares-Da-Silva P, Lokhandwala MF. Aging, high salt intake, and renal dopaminergic activity in Fischer 344 rats. Hypertension 34: 666-672, 1999.
61. +-ATPase in the rat remnant kidney. Am J Physiol Renal Physiol 279: F1033-F1044, 2000.
62. Wilczynski EA, Leenen FH. Prevention of hypertension and maintenance of normotension in spontaneously hypertensive rats is dependent on continuous severe dietary sodium restriction. Can J Physiol Pharmacol 65: 573-578, 1987.
63. + exchanger interactions in the kidney in hypertension. Hypertension 36: 395-399, 2000.
64. Yagil C, Hubner N, Kreutz R, Ganten D, Yagil Y. Congenic strains confirm the presence of salt sensitivity QTLs on chromosome 1 in the Sabra rat model of hypertension. Physiol Genomics 12: 85-95, 2003.
65. Yagil C, Hubner N, Monti J, Schulz H, Sapojnikov M, Luft FC, Ganten D, Yagil Y. Identification of hypertension-related genes through an integrated genomic-transcriptomic approach. Circ Res 96: 617-625, 2005.
66. Yagil C, Sapojnikov M, Kreutz R, Katni G, Lindpaintner K, Ganten D, Yagil Y. Salt susceptibility maps to chromosomes 1 and 17 with sex specificity in the Sabra rat model of hypertension. Hypertension 31: 119-124, 1998.
67. Yoshimura M, Ikegaki I, Nishimura M, Takahashi H. Role of dopaminergic mechanisms in the kidney for the pathogenesis of hypertension. J Auton Pharmacol 10, Suppl 1: s67-s72, 1990.
68. Zeng C, Sanada H, Watanabe H, Eisner GM, Felder RA, Jose PA. Functional genomics of the dopaminergic system in hypertension. Physiol Genomics 19: 233-246, 2004.